×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 9: Development of the Risk Management Strategy and Authoring Risk Management Documents
Session Chair(s)
Carla Barrett, PharmD
Vice President, Global Risk Management
Novavax, United States
- This session will provide details on how to develop the risk management strategy by defining a product’s risks to patients, developing a plan for pharmacovigilance, developing a plan for risk minimization, determining how to implement the actions, and addressing regional variations of risk management strategies. This session will also describe the process for authoring Risk Management Documents such as EU-REMPs and REMS, as well as related safety documents.
Have an account?